Catalio Capital Management is a multi-strategy investment firm focused on investing in breakthrough biomedical technology and innovative healthcare companies worldwide. Founded by George Petrocheilos and Dr. Jacob Vogelstein, the firm aims to leverage the expertise of world-renowned scientist-entrepreneurs to drive innovation in the biomedical sector.
Focus Areas
Investment Types
Notable Investments
